Moderna, Inc. – Consensus ‘buy’ rating and 55.7% Upside Potential

Broker Ratings

Moderna, Inc. which can be found using ticker (MRNA) have now 15 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between 393.02 and 85 with the average target price sitting at $199.98. Now with the previous closing price of $128.41 this indicates there is a potential upside of 55.7%. There is a 50 day moving average of $144.26 and the 200 moving average now moves to $156.91. The market cap for the company is 49.87B. The current stock price for Microsoft Corporation is currently 129.3 USD

The potential market cap would be $77,670,912,011 based on the market consensus.

USD

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 11.15, revenue per share of 38.61 and a 11.66% return on assets.

Share on:
Find more news, interviews, share price & company profile here for:

      Search

      Search